Replies to post #4251 on Xechem International Inc. (fka XKEM)

[xZx]

if the drug is a success then a JV to create more drug is a slam dunk.

as for monday, i think the stock will continue to rally. the story hasn't changed, but monday traders won't "head for cash" and flip the stock for beer money.

[xZx]

hardasset, check out this post:

http://www.investorshub.com/boards/read_msg.asp?message_id=11510553

let's say this extremely conservative 100k patients figure you mentioned is correct, for initial production, instead of 4 million patients... that's 100k/4M = .025... so using the math below we get $10 x .025 = .25 per share. still a bargain at .03, wouldn't you say? i sure would! even if they are somehow limited to 100,000 patients (and i highly doubt this, i'm only playing your side of the argument).

as i posted earlier, i do think they will have a pharma partner to help crank out more medicine, very quickly if not overnight, when nigerian approval comes. in fact, why wouldn't XKEM be lining up manufacturing partners already?

i also find the .25 number insanely undervalued because typical biotechs have much higher mulitples, especially if they have no competition. orphan status allows XKEM to market their drug exclusively for 7 years! what do you think the pps will be a few days after the nigerian drug approval comes? probably .25 or higher. just a guess... but i'll bet you i'm right on the mark.

here's the text from the above link:


In Nigeria alone, there are 4,000,000 SCD patients.

NICOSAN™ $20/month (conservative) = $240/year

$240 x 4,000,000 scd patients = $960,000,000 US dollars.

Multiply by a Price to Sales Ratio ratio of 21.25
(the ratio of Market capitalization to Annual Revenue).

The industry average for Pharma is 21.25, which means, if XKEM had $10M in annual sales it should have a market cap of $212M.

Let's continue...

$960,000,000 * 21 = approx $20,000,000,000

Divide by the number of shares
(let's say 1.9 Billion, max float available at this time)

$20,000,000,000 / 1,900,000,000 = $10.00

Now let's say they only get to sell to 5% of the people.[/]

Why only 5 percent you ask ?
- difficulty to ramp up production at first ..
- not everyone can afford it

5% of $10.00 = .50 stock.. (easy 15 bagger)

Now add the the rest of Africa (another 5 million cases)

And now we are over a dollar.

Now add the rest of the world....

Getting the picture...

Still want to sell your stock under .25...

Oh yes let's not forget the rest of XKEM's portfolio of drugs.

[paycheck]

hardasset, they can only make enough drug for 100,000 people because the facility is not big enough to make more. It's not because they can only grow a cretain amount of plants.
They are getting financing to add on the facilities. They said this would start immediately.

[oilstrike]

That is a false post. You have misconstrued the current product output capabillity in place of the FORESTS of basic ingredients. Don't be a dumbass. Quit drinking. No wonder you're poor and groping with your subtle basher bullchit. If you had paid attention the past three to four months, and gotten smart, then you wouldn't appear to be a weak little lemming

[Braden32601]

hardasset-oil is right! quit the XKEM subtle bashing...either buy the stock or go elsewhere!